MyAverix Finance
HK · Healthcare
Tot Biopharm International Co Ltd (1875)
Biotechnology
Tot Biopharm International Co Ltd (1875) is listed on HK in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported market cap is $3.21B, P/E ratio is 18.00, net margin is -13.4%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 1875
Tot Biopharm International Co Ltd (1875) — FAQ
What is Tot Biopharm International Co Ltd's market cap?
Tot Biopharm International Co Ltd (1875) has a reported market cap of $3.21B (data as of 2026-05-21).
What is 1875's P/E ratio?
The price-to-earnings (P/E) ratio for Tot Biopharm International Co Ltd (1875) is 18.00 (data as of 2026-05-21).
Does Tot Biopharm International Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Tot Biopharm International Co Ltd (1875). Check the MyAverix Finance app for the latest dividend data.
What sector is Tot Biopharm International Co Ltd in?
Tot Biopharm International Co Ltd (1875) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 1875 listed on?
1875 is listed on HK.
What is Tot Biopharm International Co Ltd's net margin?
Tot Biopharm International Co Ltd (1875) reports a net margin of -13.4% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.